Back to all Representative Matters
May 10, 2013

A&B Represents Cytochroma Canada Inc. in its Sale to Opko Health, Inc. for Gross Sale Proceeds of up to US$290 Million

On March 4, 2013, a subsidiary of OPKO Health, Inc. (NYSE:OPK), a multi-national biopharmaceutical and diagnostics company, completed the acquisition of all of the assets and undertaking of Cytochroma Canada Inc., a privately held pharmaceutical company with operations in Markham, Ontario and Bannockburn, Illinois. Cytochroma's lead products include CTAP101 Capsules, a vitamin D prohormone to treat secondary hyperparathyroidism (SHPT) in patients with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency, and Fermagate Tablets, a new and potent non-absorbed phosphate binder to treat hyperphosphatemia in CKD patients on chronic hemodialysis. The purchase price paid on closing was approximately US$100 Million and was satisfied by the issuance of OPKO common stock to Cytochroma. There is also an earn-out component for up to an additional US$190 Million, which is payable upon the satisfaction of certain regulatory and revenue milestones.

Cytochroma Canada Inc. was represented in Canada by Aird & Berlis LLP, with a team that included Richard Kimel, Tom Fenton, James Leech and Anne Markle (corporate finance), Barbara Worndl (tax), Aaron Collins (financial services) and Grant Cansfield (intellectual property); and in the United States by Cooley LLP, with a team that included Glen Sato (corporate/securities).

Related Representative Matters

Representative Matters
Maritime Resources Completes $8.7 Million Bought Deal Private Placement Jeffrey K. Merk, Melanie Cole, Liam Tracey-Raymont, Russell J. Sanders, Carol J. Burns, Barbara Worndl and Vernon Lin Aug 21, 2020 Maritime Resources Corp., a Canadian gold mining and exploration company, completed a bought deal... Maritime Resources Corp., a Canadian gold mining and exploration company, completed a bought deal private placement of common shares and flow-through common shares for aggregate gross proceeds of approximately $8.7 million.
Representative Matters
Energy+ Closes $55 Million Offering of Unsecured Debentures Jill P. Fraser, Melanie Cole and Meredith McCann Aug 10, 2020 On August 10, 2020, Energy+ Inc. closed a $55 million offering of 2.968% senior unsecured debentu... On August 10, 2020, Energy+ Inc. closed a $55 million offering of 2.968% senior unsecured debentures due August 10, 2060.
Representative Matters
Nextleaf Solutions Ltd. Completes Acquisition of Licensed Processor Melanie Cole, Alicia McKeag, Barbara Worndl and Saam Nainifard Aug 04, 2020 Nextleaf Solutions Ltd., an innovative Canadian cannabis extractor, recently completed the acquis... Nextleaf Solutions Ltd., an innovative Canadian cannabis extractor, recently completed the acquisition of all of the issued and outstanding shares of Nextleaf Labs Ltd., a company that holds Health Canada standard processing and research licenses under the Cannabis Act (Canada).